ESC Professional Premium Access

Risk factors and clinical effects of late leaflet thrombosis after transcatheter aortic valve replacement

Congress Session

About the speaker

Doctor Minjung Bak

Samsung Medical Center, Seoul (Korea (Republic of))
0 follower

4 more presentations in this session

To compare efficacy and safety of direct oral anticoagulants in patients with concurrent atrial fibrillation and bioprosthetic heart valve repair or replacement: a systematic review and meta-analysis

Speaker: Doctor A. Kaur (New York City, US)

Thumbnail

Oral anticoagulant treatment in patients with atrial fibrillation early after valvular intervention: a nationwide cohort study

Speaker: Associate Professor C. Christersson (Uppsala, SE)

Thumbnail

Comparing direct oral anticoagulants versus vitamin k antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement: an updated meta-analysis

Speaker: Doctor A. Kaur (New York City, US)

Thumbnail

Hypoattenuated leaflet thickening is associated with silent brain injury

Speaker: Doctor A. Nagy (Budapest, HU)

Thumbnail

Access the full session

Thrombosis and anticoagulation in valvular heart disease

Speakers: Doctor M. Bak, Doctor A. Kaur, Associate Professor C. Christersson, Doctor A. Kaur, Doctor A. Nagy
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk